Alivus Life Sciences FY26 Annual Report: Revenue up 6.9%, EBITDA margin at 33.6%

Ebitda Margin ExpansionResults View source PDF Explain this filing

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹1385.50

prior close

₹1393.60

announcement price

After-mkt

timing

Nifty Microcap 250market+0.4%-2.9% vs market

Pharmaceuticals peers, median of 165sector-0.6%-1.9% vs sector

On the reaction day the stock moved 2.9 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-1.1

15m

-1.2

30m

-2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5+0.4-2.9-0.6-1.9

Next day

-0.6+0.5-1.1-0.3-0.3

+0.7+0.6+0.1-0.7+1.3

+0.7+0.7-0.0-1.4+2.1

+1.0+1.1-0.1-1.1+2.1

-1.5+0.5-2.0-2.0+0.5

-2.1+1.3-3.4-1.2-0.8

15d

+2.1+0.5+1.6-1.0+3.1

-3.0-0.8-2.1-0.2-2.8

-3.3-0.9-2.3-3.2-0.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alivus Life Sciences (formerly Glenmark Life Sciences) filed its FY25-26 Integrated Annual Report. Revenue grew 6.9 percent to INR 25,518 million. EBITDA jumped 19.6 percent to INR 8,577 million with margin expanding 360 bps to 33.6 percent. PAT rose 16.1 percent to INR 5,645 million; EPS at INR 45.99. Company is net debt-free with INR 7,824 million cash. Plans around INR 540 crore capex in FY27 funded entirely from internal accruals.

Likely market impact

Strong FY26 with record 33.6 percent EBITDA margin, debt-free balance sheet and INR 540 crore FY27 capex plan signal growth momentum.